当前位置: 首页 > 期刊 > 《世界华人消化杂志》 > 2007年第11期
编号:11495709
RNA干扰在胃癌治疗中的研究进展
http://www.100md.com 2007年4月18日 章 琎, 方国恩, 王嘉锋
RNA干扰;胃癌;基因治疗,章琎,方国恩,王嘉锋,通讯作者:,ProgressofRNAinterferenceinthetherapyofgastriccancer,JinZhang,Guo-EnFang,Jia-FengWang,Correspon
第1页

    参见附件(833KB,5页)。

     章琎, 方国恩, 王嘉锋, 中国人民解放军第二军医大学长海医院普外科 上海市 200433

    通讯作者:
章琎, 200433, 上海市, 中国人民解放军第二军医大学长海医院普外科. zhangjin_sh@126.com

    电话: 021-65504407

    收稿日期: 2006-12-04 接受日期: 2007-02-12

    Progress of RNA interference in the therapy of gastric cancer

    
Jin Zhang, Guo-En Fang, Jia-Feng Wang

    Jin Zhang, Guo-En Fang, Jia-Feng Wang,
Department of General Surgery, Changhai Hospital of the Second Military Medical University, Shanghai 200433, China

    Correspondence to:
Jin Zhang, Department of General Surgery, Changhai Hospital of the Second Military Medical University, Shanghai 200433, China. zhangjin_sh@126.com

    Received:
2006-12-04 Accepted:2007-02-12

    Abstract

    RNA interference (RNAi) is a new gene-silencing technique, which is a post-transcriptional gene silencing mediated by double-stranded RNA, resulting in the sequence-specific silence of target gene. RNAi technique has been applied widely in the research of various tumors, and most of the results have shown that it could specifically inhibited the expression of oncogenes, cancer-related genes and mutant genes, so as to suppress the occurrence and development of tumors. Meanwhile, explorations have also been performed on the therapy of gastric cancer, and some significant advances have been obtained. RNAi technique can not only act on the target genes directly, but also treat gastric cancer indirectly by restraining the angiogenesis. Furthermore, RNAi technique can be used to resist the multi-drug resistance during chemotherapy.

    Key Words: RNA interference; Gastric cancer; Gene therapy

    Zhang J, Fang GE, Wang JF. Progress of RNA interference in the therapy of gastric cancer. Shijie Huaren Xiaohua Zazhi 2007;15(11):1252-1256

    摘要

    RNA干扰(RNAi)是近几年发展起来的一种新兴的基因沉默技术, 他是由双链RNA介导的靶向基因序列特异性转录后沉默机制. 目前, RNAi技术已被广泛应用于各种肿瘤研究, 结果发现其可特异地抑制癌基因、癌相关基因或突变基因的过度表达, 从而抑制肿瘤的发生、发展. 同时RNAi技术在胃癌治疗方面也进行了许多积极的探索, 取得了一些突破性进展 ......

您现在查看是摘要介绍页,详见PDF附件(833KB,5页)